BURNETT JOSEPH 4

4 · ClearPoint Neuro, Inc. · Filed Mar 10, 2026

AI-generated summary of this filing

Updated Mar 11, 2026

ClearPoint Neuro (CLPT) CEO Joseph Burnett Receives RSU Shares

What Happened

Joseph M. Burnett, CEO, President and Director of ClearPoint Neuro (CLPT), had 47,407 restricted stock units (RSUs) settle on their scheduled vesting date (conversion of derivative to common stock) on 2026-03-06.
To satisfy tax withholding, 22,709 of those shares were delivered back to the company at $10.00 per share for $227,090. That left a net issuance of 24,698 shares to the Joseph M. Burnett Trust (he is trustee).

Key Details

Transaction date: 2026-03-06; Form 4 filed: 2026-03-10 (filed within the two-business-day rule).
Vesting/Conversion: 47,407 RSUs converted to common shares (transaction code M).
Tax withholding: 22,709 shares withheld (transaction code F) at $10.00/share for $227,090.
Net shares issued to trustee: 24,698 (47,407 − 22,709). Total shares owned after the transaction is not reported on the provided data.
Footnotes: F1—these were RSUs settled into common stock; F2—shares delivered to CLPT satisfied tax withholding; F3—the shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Mr. Burnett as trustee.

Context

This was an RSU vesting/settlement, not an open-market purchase or sale; withholding shares for taxes is a routine administrative step and not necessarily a signal of sentiment.
The filing shows conversion of a derivative (RSUs) into common stock and a share-withholding tax payment (similar to a cashless settlement).

Form 4

Period: 2026-03-06

DirectorCEO and President

Transactions

Exercise/Conversion
Common Stock
[F1]
2026-03-06+47,407→ 76,941 total
Tax Payment
Common Stock
[F2]
2026-03-06$10.00/sh−22,709$227,090→ 54,232 total
Exercise/Conversion
Restricted Stock Units
[F1]
2026-03-06−47,407→ 0 total
→ Common Stock (47,407 underlying)

Holdings

Footnotes (3)

[F1]Each restricted stock unit represents a contingent right to receive one share of ClearPoint Neuro, Inc. ("CLPT") common stock. This transaction represents the settlement of restricted stock units in shares of common stock on their scheduled vesting date.
[F2]Represents the amount of shares delivered to CLPT to satisfy applicable tax withholding obligations in connection with the vesting of shares of restricted stock.
[F3]These shares are owned directly by the Joseph M. Burnett Trust dated 10/20/2022 and indirectly by Joseph M. Burnett as trustee of the trust.

Signature

/s/ Danilo D'Alessandro, by Power of Attorney for Joseph M. Burnett|2026-03-10

1 file